Media & Press2019-09-17T16:08:49-04:00

    Bexion Pharmaceuticals, Inc. To Present Clinical Data at 2019 NORD Annual Meeting

    September 4, 2019|

    Clinical results support strong safety and tolerability for BXQ-350. Topline results support progression into Phase II studies. FOR IMMEDIATE RELEASE Covington, KY ~ 4 September 2019 Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on rare brain and solid tumors, announced today that it will feature a clinical poster presentation at the National Organization for ... Read More

    All Press